MOH on NYSE

Molina Healthcare

Logo: Molina Healthcare, Public domain, via Wikimedia Commons⁶

American-managed healthcare insurance company

Molina Healthcare, Inc. is an American managed care company headquartered in Long Beach, California.³ From Wikipedia, CC BY-SA 4.0

$206.86 down 5.64 (2.65%)Price as of Oct 16, 2026 at 19:58 UTC

Last updated Oct 19, 2026.

Overview

1980Founded¹

Compare with Humana, Centene Corporation or Elevance Health, Inc., or pick any stock.

TickerMOH on NYSE¹
Industryhealth care industry¹
HeadquartersLong Beach¹
Websitemolinahealthcare.com
Legal formDelaware corporation¹
Incorporated inDE⁷
Business address200 Oceangate, Suite 100, Long Beach, Ca 90802⁷
Filer categoryLarge accelerated filer⁷
LEI549300NQQCEQ46YHZ591⁴
StatusActive⁴
LEI statusIssued and current⁴
Registered addressc/o CORPORATION SERVICE COMPANY, 251 LITTLE FALLS DRIVE, 19808 Wilmington, United States⁴
Registered withDivision of Corporations, Department of State, 3551135⁴

See how the biggest companies compare on our leaderboards

Molina Healthcare, Inc. is an American managed care company headquartered in Long Beach, California. The company provides health insurance to individuals through government programs such as Medicaid and Medicare.³

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

1.7%Operating margin⁹

1.0%Net margin⁹

11.7%Revenue growth, 2025⁹

11.6%Return on equity⁹

0.93×Debt to equity⁹

-$636.0MFree cash flow⁹

Where the money goes

Where each dollar of revenue went, fiscal 2025

Cost of revenueOther costs

Cost of revenue87¢$39.5B
Other costs12¢$5.3B
Income tax0¢$117.0M
Profit1¢$472.0M

Out of $45.4B in revenue.⁹

Financial statements

Revenue¹⁰¹¹¹²¹³⁹$45.4B in 2025+170% since 2019

Gross profit¹⁴$2.5B in 2020+8% since 2019

Operating income¹⁰¹¹¹²¹³⁹$781.0M in 2025−25% since 2019

Net income¹⁰¹¹¹²¹³⁹$472.0M in 2025−36% since 2019

Every line of the income statement as filed: the last 3 fiscal years, latest first.⁹

Period ending	2025-12-31	2024-12-31	2023-12-31
Premium revenue	$43.1B	$38.6B	$32.5B
Premium tax revenue	$1.9B	$1.5B	$1.1B
Investment income	$420.0M	$452.0M	$394.0M
Other revenue	$91.0M	$85.0M	$80.0M
Total revenue	$45.4B	$40.6B	$34.1B
Medical care costs	$39.5B	$34.4B	$28.7B
General and administrative expenses	$3.0B	$2.7B	$2.5B
Premium tax expenses	$1.9B	$1.5B	$1.1B
Depreciation and amortization	$195.0M	$186.0M	$171.0M
Other	$90.0M	$100.0M	$128.0M
Total operating expenses	$44.6B	$38.9B	$32.5B
Operating income	$781.0M	$1.7B	$1.6B
Interest expense	$192.0M	$118.0M	$109.0M
Income before income tax expense	$589.0M	$1.6B	$1.5B
Income tax expense	$117.0M	$410.0M	$373.0M
Net income	$472.0M	$1.2B	$1.1B
Basic (in dollars per share)	$8.93	$20.52	$18.91
Diluted (in dollars per share)	$8.92	$20.42	$18.77
Basic (in shares)	52.8M shares	57.4M shares	57.7M shares
Diluted (in shares)	52.9M shares	57.7M shares	58.1M shares

Total assets¹⁴¹⁰¹¹¹²¹³⁹$15.6B in 2025+129% since 2019

Total liabilities¹⁴¹⁰¹¹¹²¹³⁹$11.5B in 2025+138% since 2019

Shareholders’ equity¹¹¹²¹³⁹$4.1B in 2025+108% since 2019

Cash¹⁰¹¹¹²¹³⁹$4.2B in 2025+73% since 2019

Long-term debt¹⁴¹⁰¹¹¹²¹³⁹$3.8B in 2025+204% since 2019

Every line of the balance sheet as filed: the last 4 fiscal years (annual) or 4 quarters (quarterly), latest first.⁹

Period ending	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Cash and cash equivalents	$4.2B	$4.7B	$4.8B
Investments	$4.0B	$4.3B
Receivables	$3.5B	$3.3B
Prepaid expenses and other current assets	$655.0M	$487.0M
Total current assets	$12.4B	$12.8B
Property, equipment, and capitalized software, net	$301.0M	$288.0M
Goodwill and intangible assets, net	$2.2B	$1.9B
Restricted investments	$299.0M	$286.0M
Deferred income taxes, net	$178.0M	$207.0M
Other assets	$147.0M	$138.0M
Total assets	$15.6B	$15.6B
Medical claims and benefits payable	$4.9B	$4.6B	$4.2B	$3.5B
Amounts due government agencies	$1.3B	$1.9B
Accounts payable, accrued liabilities and other	$1.1B	$1.3B
Deferred revenue	$66.0M	$51.0M
Total current liabilities	$7.4B	$7.9B
Long-term debt	$3.8B	$2.9B
Finance lease liabilities	$184.0M	$195.0M
Other long-term liabilities	$173.0M	$120.0M
Total liabilities	$11.5B	$11.1B
Common stock, $0.001 par value per share; 150 million shares authorized; outstanding: 51 million shares at December 31, 2025, and 56 million at December 31, 2024	$0	$0
Preferred stock, $0.001 par value per share; 20 million shares authorized, no shares issued and outstanding	$0	$0
Additional paid-in capital	$452.0M	$462.0M
Accumulated other comprehensive income (loss)	$15.0M	-$57.0M
Retained earnings	$3.6B	$4.1B
Total stockholders equity	$4.1B	$4.5B	$4.2B	$3.0B
Total liabilities and stockholders equity	$15.6B	$15.6B
Common stock, par value (in dollars per share)	$0.00	$0.00
Common stock, shares authorized (in shares)	150.0M shares	150.0M shares
Common stock, shares, outstanding (in shares)	51.0M shares	56.0M shares
Preferred stock, par value (in dollars per share)	$0.00	$0.00
Preferred stock, shares authorized (in shares)	20.0M shares	20.0M shares
Preferred stock, shares issued (in shares)	0 shares	0 shares
Preferred stock, shares outstanding (in shares)	0 shares	0 shares

Period ending	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Cash and cash equivalents	$4.2B	$4.7B	$4.8B
Investments	$4.0B	$4.3B
Receivables	$3.5B	$3.3B
Prepaid expenses and other current assets	$655.0M	$487.0M
Total current assets	$12.4B	$12.8B
Property, equipment, and capitalized software, net	$301.0M	$288.0M
Goodwill and intangible assets, net	$2.2B	$1.9B
Restricted investments	$299.0M	$286.0M
Deferred income taxes, net	$178.0M	$207.0M
Other assets	$147.0M	$138.0M
Total assets	$15.6B	$15.6B
Medical claims and benefits payable	$4.9B	$4.6B	$4.2B	$3.5B
Amounts due government agencies	$1.3B	$1.9B
Accounts payable, accrued liabilities and other	$1.1B	$1.3B
Deferred revenue	$66.0M	$51.0M
Total current liabilities	$7.4B	$7.9B
Long-term debt	$3.8B	$2.9B
Finance lease liabilities	$184.0M	$195.0M
Other long-term liabilities	$173.0M	$120.0M
Total liabilities	$11.5B	$11.1B
Common stock, $0.001 par value per share; 150 million shares authorized; outstanding: 51 million shares at December 31, 2025, and 56 million at December 31, 2024	$0	$0
Preferred stock, $0.001 par value per share; 20 million shares authorized, no shares issued and outstanding	$0	$0
Additional paid-in capital	$452.0M	$462.0M
Accumulated other comprehensive income (loss)	$15.0M	-$57.0M
Retained earnings	$3.6B	$4.1B
Total stockholders equity	$4.1B	$4.5B	$4.2B	$3.0B
Total liabilities and stockholders equity	$15.6B	$15.6B
Common stock, par value (in dollars per share)	$0.00	$0.00
Common stock, shares authorized (in shares)	150.0M shares	150.0M shares
Common stock, shares, outstanding (in shares)	51.0M shares	56.0M shares
Preferred stock, par value (in dollars per share)	$0.00	$0.00
Preferred stock, shares authorized (in shares)	20.0M shares	20.0M shares
Preferred stock, shares issued (in shares)	0 shares	0 shares
Preferred stock, shares outstanding (in shares)	0 shares	0 shares

Cash from operations¹⁰¹¹¹²¹³⁹-$535.0M in 2025

Capital spending¹⁰¹¹¹²¹³⁹$101.0M in 2025+77% since 2019

Free cash flow¹⁰¹¹¹²¹³⁹-$636.0M in 2025

Share buybacks¹⁰¹¹¹²¹³⁹$1.0B in 2025+2028% since 2019

Every line of the cash flow as filed: the last 3 fiscal years, latest first.⁹

Period ending	2025-12-31	2024-12-31	2023-12-31
Net income	$472.0M	$1.2B	$1.1B
Depreciation and amortization	$195.0M	$186.0M	$171.0M
Deferred income taxes	$43.0M	$53.0M	-$31.0M
Share-based compensation	$47.0M	$116.0M	$115.0M
Other, net	-$3.0M	$8.0M	$2.0M
Receivables	-$145.0M	-$78.0M	-$778.0M
Prepaid expenses and other current assets	$52.0M	-$57.0M	-$69.0M
Medical claims and benefits payable	-$132.0M	-$40.0M	$580.0M
Amounts due government agencies	-$591.0M	-$453.0M	$196.0M
Accounts payable, accrued liabilities and other	-$221.0M	$115.0M	$328.0M
Deferred revenue	-$51.0M	-$367.0M	$59.0M
Income taxes	-$201.0M	-$18.0M	-$2.0M
Net cash (used in) provided by operating activities	-$535.0M	$644.0M	$1.7B
Purchases of investments	-$751.0M	-$1.1B	-$1.4B
Proceeds from sales and maturities of investments	$1.4B	$1.1B	$772.0M
Net cash paid in business combinations	-$245.0M	-$344.0M	-$3.0M
Purchases of property, equipment and capitalized software	-$101.0M	-$100.0M	-$84.0M
Other, net	$1.0M	$1.0M	$4.0M
Net cash provided by (used in) investing activities	$312.0M	-$464.0M	-$744.0M
Proceeds from borrowings under credit facility and term loans	$1.1B	$300.0M	$0
Repayment of credit facility and term loans	-$1.1B	-$300.0M	$0
Common stock purchases	-$1.0B	-$1.0B	$0
Proceeds from senior notes offerings, net of issuance costs	$838.0M	$740.0M	$0
Common stock withheld to settle employee tax obligations	-$37.0M	-$57.0M	-$60.0M
Other, net	$29.0M	-$30.0M	$2.0M
Net cash used in financing activities	-$170.0M	-$347.0M	-$58.0M
Net (decrease) increase in cash and cash equivalents, and restricted cash and cash equivalents	-$393.0M	-$167.0M	$860.0M
Cash paid during the period for interest	$181.0M	$121.0M	$108.0M

Compare Molina Healthcare with another company

The story

Molina Healthcare was founded in 1980 by C. David Molina, an emergency room physician in Long Beach, California. He had seen an influx of patients using the emergency room for common illnesses such as a sore throat or the flu because they were being turned away by doctors who would not accept Medi-Cal. Molina established his first primary care clinic with the goal of treating the lowest-income patients, regardless of their ability to pay.

From Wikipedia’s article on Molina Healthcare, shared under CC BY-SA 4.0.⁸

Leadership

Who has led Molina Healthcare, and when. Pick a name to see everywhere that person has worked.

Chief executive

President

Joseph M. Zubretsky2017–now

Chief financial officer

Chief operating officer

1990200020102020

Chief executive officerJoseph M. Zubretsky Nov 6, 2017 to now¹⁷
Chief executive officerGeorge Kirk Olsen Jan 4, 2006 to Jan 3, 2007¹⁸
Chief executive officerJoann Zarza-Garrido Jan 4, 2006 to Mar 7, 2006¹⁹
Chief executive officerRoman Kulich Feb 6, 2006 to Aug 23, 2007²⁰
PresidentJoseph M. Zubretsky Nov 6, 2017 to now¹⁷
Chief financial officerMark Lowell Keim Mar 3, 2021 to now²¹
Chief financial officerJoseph W. Cpa White Mar 2, 2018 to Jun 6, 2018²²
Chief financial officerThomas L. Tran May 30, 2018 to Jul 2, 2020²³
Chief financial officerJohn C. Molina Sep 14, 2006 to Apr 4, 2017²⁴
Chief operating officerJames Woys Jul 3, 2023 to now²⁵
Chief operating officerTerry Bayer Jan 4, 2006 to Feb 6, 2018²⁶

Board members and other officers (40)

EVP, MedicaidDebra Bacon Feb 2, 2024 to now²⁷
Executive Vice PresidentMarc Russo Apr 1, 2020 to Aug 7, 2023²⁸
Chief Accounting OfficerMaurice Hebert Feb 19, 2019 to now²⁹
Executive Vice PresidentMark Lowell Keim Mar 16, 2018 to Jan 11, 2021³⁰
Executive Vice PresidentPamela Sedmak Mar 16, 2018 to Mar 3, 2020³¹
Executive Vice PresidentJames Woys May 22, 2018 to Mar 3, 2023³²
Senior Vice PresidentLisa A. Rubino Aug 11, 2016 to Mar 2, 2018³³
Chief Medical OfficerMichael M. Siegel Feb 16, 2007 to Mar 5, 2007³⁴
VP, Molina AdvantageGeorge Kirk Olsen Feb 28, 2007 to Jul 2, 2007³⁵
VP, ComplianceJoann Zarza-Garrido Mar 2, 2007 to Mar 2, 2007³⁶
Chief Medical OfficerJames W. Howatt May 29, 2007 to Mar 23, 2010³⁷
Chief Information OfficerAmir Desai Nov 15, 2007 to Aug 17, 2010³⁸
Regional Vice PresidentZarina Sparling Nov 15, 2007 to Jul 2, 2008³⁹
VP, Internal AuditingHarvey A. Fein Jan 4, 2006 to Mar 5, 2007⁴⁰
VP, AccountingJoseph W. Cpa White Jan 4, 2006 to Apr 4, 2017⁴¹
VP, Health Plan OperationsLillis Ann Koontz Jan 4, 2006 to Jul 2, 2008⁴²
Exec. VP, Shared ServicesSheila Shapiro Jan 4, 2006 to Jan 4, 2006⁴³
Chief Information OfficerRick Click Feb 6, 2006 to Mar 5, 2007⁴⁴
Chief Medical OfficerWilliam Bracciodieta Feb 6, 2006 to Feb 21, 2007⁴⁵
Exec. V.P., Financial AffairsJohn C. Molina Dec 13, 2006 to Dec 13, 2006⁴⁶
Board memberFrancis S. Soistman Jr. May 6, 2026 to now⁴⁷
Board memberLeo P. Grohowski May 2, 2025 to now⁴⁸
Board memberStephen H. Lockhart May 11, 2021 to now⁴⁹
Board memberBarbara L. Brasier May 17, 2019 to now⁵⁰
Board memberRichard C. Zoretic Aug 1, 2018 to now⁵¹
Board memberJoseph M. Zubretsky Nov 6, 2017 to now¹⁷
Board memberRichard M. Schapiro Aug 4, 2015 to now⁵²
Board memberDale B. Wolf Mar 13, 2013 to now⁵³
Board memberDaniel Cooperman Mar 13, 2013 to now⁵⁴
Board memberGarrey Carruthers Feb 22, 2012 to Apr 2, 2021⁵⁵
Board memberSteven J. Orlando Mar 2, 2006 to now⁵⁶
Board memberCharles Z. Fedak May 5, 2006 to Apr 3, 2019⁵⁷
Board memberFrank E. Murray Md. May 5, 2006 to Oct 2, 2017⁵⁸
Board memberJohn P. Szabo Jr. May 5, 2006 to Apr 3, 2015⁵⁹
Board memberRonna Romney May 5, 2006 to now⁶⁰
Board memberSally K. Richardson May 5, 2006 to May 3, 2012⁶¹
Board memberWayne B. Lowell Jun 14, 2006 to May 14, 2007⁶²
Board memberJohn C. Molina Sep 14, 2006 to Feb 28, 2018²⁴
General counselJeff D. Barlow Aug 10, 2012 to now⁶³
General counselMark L. Andrews Esq. Feb 6, 2006 to Jul 2, 2010⁶⁴

Products and brands

health insurance

Listed on Wikidata.¹

Entering the Medicare market

Molina Healthcare entered the Medicare market in 2006. The company currently offers Medicare health plan options in: Arizona, California, Florida, Idaho, Illinois, Kentucky, Massachusetts, Michigan, Nevada, New Mexico, New York, Ohio, South Carolina, Texas, Utah, Virginia, Washington and Wisconsin.

Entering MMIS market

Molina Healthcare acquired Unisys' health information management business in December 2010 to create Molina Medicaid Solutions (MMS). MMS has Medicaid Management Information Systems (MMIS) contracts with Idaho, Louisiana, Maine, New Jersey, West Virginia and the U.S. Virgin Islands. In Autumn 2018, Molina Healthcare, Inc. sold its Medicaid management information systems business, Molina Medicaid Solutions (MMS), to DXC Technology. MMS was a wholly owned subsidiary of Molina Healthcare at the time of sale.

Entering health insurance marketplace

In 2014, Molina Healthcare began offering Marketplace plans in nine states where it offered Medicaid health plans through State Facilitated Marketplaces and Federally Facilitated Marketplace. On November 16, 2016 the Seattle Times reported that about 11 million people currently get their coverage through the exchange. In August 2017 Molina announced it would stop offering plans on the health insurance marketplaces in Utah, Wisconsin, and Maine in 2018.

From Wikipedia’s article on Molina Healthcare, shared under CC BY-SA 4.0.⁸

Former names

MOLINA HEALTHCARE INCDec 30, 2002 to Jul 3, 2019⁷

Controversies and legal

Criticism and controversies

A 2023 report investigating "High Rates of Prior

Authorization Denials" reported that Molina Healthcare's Medicaid plans for financially vulnerable people had some of the highest denial percentages in the country. It was reported, that Molina Healthcare operated plans that denied medical care under requests for prior authorization of services in more than 25% of cases in 2019. About 2.7 million people were enrolled in these plans at the time, while another 8.4 million people were enrolled in plans with denial rates higher than average at 15-25%. Some plans had even higher denial rates, as their Illinois plan 41% of requests.

From Wikipedia’s article on Molina Healthcare, shared under CC BY-SA 4.0.⁸

Timeline

Nov 6, 2017New chief executive Joseph M. Zubretsky becomes CEO¹⁷
Feb 6, 2006New chief executive Roman Kulich becomes CEO²⁰
Jan 4, 2006New chief executive George Kirk Olsen becomes CEO¹⁸
Jan 4, 2006New chief executive Joann Zarza-Garrido becomes CEO¹⁹
1980Founded Founded¹

Filings

477 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 77 major events, 290 insider forms, 42 large holders, 48 other. The latest 20:

Oct 2, 20264 EDGAR
Oct 2, 20264 EDGAR
Oct 2, 20264 EDGAR
Oct 2, 20264 EDGAR
Oct 2, 20264 EDGAR
Oct 2, 20264 EDGAR
Oct 2, 20264 EDGAR
Oct 2, 20264 EDGAR
Oct 2, 20264 EDGAR
Sep 3, 2026SCHEDULE 13G EDGAR
Aug 13, 2026SCHEDULE 13G/A EDGAR
Aug 12, 2026SCHEDULE 13G/A EDGAR
Aug 6, 2026SCHEDULE 13G/A EDGAR
Jul 23, 202610-Q EDGAR
Jul 22, 20268-K EDGAR
Jul 2, 20264 EDGAR
Jul 2, 20264 EDGAR
Jul 2, 20264 EDGAR
Jul 2, 20264 EDGAR
Jul 2, 20264 EDGAR

The 477 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

68 open-market trades by officers, directors and large owners since October 2021: 2 buys and 66 sales. Grants, option exercises and gifts are left out.

Date	Who	Trade	Shares	Price	Value	Filing
May 14, 2026	HEBERT MAURICEChief Accounting Officer	Sale	600	$191.55	$114.9K	Form 4
May 11, 2026	Barlow Jeff D.Chief Legal Officer	Sale	17,811	$186.12	$3.3M	Form 4
Mar 12, 2026	ROMNEY RONNADirector	Sale	506	$146.92	$74.3K	Form 4
Feb 11, 2026	ZORETIC RICHARD CDirector	Buy	800	$125.16	$100.1K	Form 4
Nov 24, 2025	Schapiro Richard MDirector	Sale	357	$143.02	$51.1K	Form 4
Aug 6, 2025	ROMNEY RONNADirector	Sale	700	$153.74	$107.6K	Form 4
Aug 4, 2025	WOYS JAMESChief Operating Officer	Buy	10,000	$155.94	$1.6M	Form 4
May 21, 2025	WOLF DALE BDirector	Sale	1,500	$322.89	$484.3K	Form 4
May 5, 2025	ORLANDO STEVEN JDirector	Sale	1,000	$318.58	$318.6K	Form 4
Apr 30, 2025	Zubretsky Joseph MPresident & CEO	Sale	87,500	$320.06	$28.0M	Form 4
Apr 29, 2025	Schapiro Richard MDirector	Sale	669	$320.50	$214.4K	Form 4
Mar 3, 2025	ORLANDO STEVEN JDirector	Sale	1,000	$301.33	$301.3K	Form 4
Nov 18, 2024	Schapiro Richard MDirector	Sale	136	$292.72	$39.8K	Form 4
Aug 15, 2024	HEBERT MAURICEChief Accounting Officer	Sale	393	$346.52	$136.2K	Form 4
Jul 30, 2024	ORLANDO STEVEN JDirector	Sale	1,000	$339.21	$339.2K	Form 4
Jul 29, 2024	Barlow Jeff D.Chief Legal Officer	Sale	5,340	$335.00	$1.8M	Form 4
May 22, 2024	WOYS JAMESChief Operating Officer	Sale	10,000	$345.15	$3.5M	Form 4
May 21, 2024	ROMNEY RONNADirector	Sale	250	$343.27	$85.8K	Form 4
Feb 20, 2024	Schapiro Richard MDirector	Sale	1,000	$401.05	$401.1K	Form 4
Feb 15, 2024	ORLANDO STEVEN JDirector	Sale	750	$399.12	$299.3K	Form 4

All 68 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Lingotto Investment Management LLPSCHEDULE 13G, 1 filing Sep 3, 2026⁶⁵
AQR CAPITAL MANAGEMENT LLCSCHEDULE 13G/A, 4 filings Nov 14, 2025 to Aug 13, 2026⁶⁶
Capital World InvestorsSCHEDULE 13G/A, 5 filings Feb 11, 2022 to Aug 12, 2026⁶⁷
FMR LLCSCHEDULE 13G/A, 4 filings Feb 9, 2023 to Aug 6, 2026⁶⁸
VANGUARD CAPITAL MANAGEMENT LLCSCHEDULE 13G, 1 filing Apr 30, 2026⁶⁹
VANGUARD PORTFOLIO MANAGEMENT LLCSCHEDULE 13G, 1 filing Apr 29, 2026⁷⁰
BlackRockSCHEDULE 13G/A, 2 filings Jan 21, 2026 to Apr 7, 2026⁷¹
VANGUARD GROUP INCSCHEDULE 13G/A, 5 filings Feb 10, 2022 to Mar 27, 2026⁷²
PRICE T ROWE ASSOCIATES INC /MD/SCHEDULE 13G/A, 9 filings Feb 14, 2022 to Feb 17, 2026⁷³
Capital Research Global InvestorsSCHEDULE 13G/A, 2 filings Nov 12, 2024 to Aug 13, 2025⁷⁴
Wellington Management CompanySC 13G/A, 4 filings Feb 4, 2022 to Nov 8, 2024⁷⁵
RENAISSANCE TECHNOLOGIES LLCSC 13G/A, 1 filing Feb 10, 2022⁷⁶

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.

Fund	Shares	Value	Share of the fund	Change
BlackRock, Inc.	6,572,156	$1.5B	0.0%	+203,130
Aqr Capital Management LLC	3,560,601	$806.9M	0.3%	+697,208
Vanguard Portfolio Management LLC	2,790,243	$638.1M	0.0%	−728
Capital World Investors	2,562,913	$586.1M	0.1%	−636,433
Lingotto Investment Management LLP	2,511,490	$574.4M	12.4%	New
Vanguard Capital Management LLC	2,355,261	$538.6M	0.0%	+45,031
Victory Capital Management Inc	1,980,615	$453.0M	0.3%	−90,084
Fmr LLC	1,871,290	$428.0M	0.0%	−1,333,634
State Street Corp	1,755,467	$401.5M	0.0%	+25,026
Dimensional Fund Advisors LP	1,393,338	$318.7M	0.1%	−1,544
Goldman Sachs Group Inc	1,306,563	$298.8M	0.0%	+579,678
Wellington Management Group Llp	1,267,207	$289.8M	0.1%	+135,247
Two Sigma Investments, LP	1,266,338	$289.6M	0.2%	−84,357
Capital Research Global Investors	1,092,251	$249.8M	0.0%	+4,446
Morgan Stanley	1,007,068	$230.3M	0.0%	+1,071
Harris Associates L P	957,500	$219.0M	0.3%	−20,647
Geode Capital Management, LLC	891,772	$204.0M	0.0%	−29,241
Manning & Napier Advisors LLC	663,669	$152.3M	2.0%	+118,252
UBS Group AG	624,180	$142.7M	0.0%	+151,704
Long Focus Capital Management, LLC	610,000	$139.5M	5.7%	−5,000
Charles Schwab Investment Management Inc	575,045	$131.5M	0.0%	+35,733
Invesco Ltd.	508,669	$116.3M	0.0%	+1,029
Jacobs Levy Equity Management, Inc	505,241	$115.5M	0.4%	+154,296
Northern Trust Corp	386,064	$88.3M	0.0%	+3,011
Norges Bank	380,649	$87.1M	0.0%	New

13F reports cover disclosed long positions in U.S. stocks only.

Members of Congress who traded it

11 trades disclosed by members of Congress. “Vs S&P since” is the stock’s change since the trade minus the S&P 500’s.

Date	Member	Trade	Amount	Vs S&P since	Filing
Nov 12, 2025	Gilbert Ray Cisneros, Jr.Democratic, House	Partial sale	$1,001 - $15,000	−37.7%	Report
Sep 4, 2025	Byron DonaldsRepublican, House	Sale	$1,001 - $15,000	−5.5%	Report
Sep 4, 2025	Byron DonaldsRepublican, House	Sale	$1,001 - $15,000	−5.5%	Report
Aug 5, 2025	Gilbert Ray Cisneros, Jr.Democratic, House	Buy	$1,001 - $15,000	+14.0%	Report
May 30, 2025	Gilbert Ray Cisneros, Jr.Democratic, House	Partial sale	$1,001 - $15,000	+61.3%	Report
May 15, 2025	Robert P. Bresnahan, Jr.Republican, House	Buy	$1,001 - $15,000	−63.0%	Report
Apr 29, 2025	Gilbert Ray Cisneros, Jr.Democratic, House	Buy	$1,001 - $15,000	−72.8%	Report
Jan 13, 2025	Robert P. Bresnahan, Jr.Republican, House	Sale	$1,001 - $15,000	+60.6%	Report
Jul 12, 2023	Daniel S. GoldmanDemocratic, House	Sale	$15,001 - $50,000	+100.2%	Report
Jun 15, 2023	Earl Blumenauer, House	Buy	$15,001 - $50,000	−99.5%	Report
Apr 10, 2023	Daniel S. GoldmanDemocratic, House	Buy	$15,001 - $50,000	−115.1%	Report

Members report amounts as ranges, not exact figures. Returns are price-only (no dividends).

Sources

The numbers on this page point here. Each one links to the record it came from.

1
WikidataMolina Healthcare on Wikidata
2
SEC EDGARMolina Healthcare filings on SEC EDGAR
3
WikipediaMolina Healthcare on Wikipedia
4
GLEIFMolina Healthcare LEI record (549300NQQCEQ46YHZ591)
5
Yahoo FinanceMOH quote
6
Wikimedia CommonsMolina Healthcare logo by Molina Healthcare, Public domain
7
SEC EDGARMolina Healthcare filings on SEC EDGAR
8
WikipediaMolina Healthcare on Wikipedia (revision used)
9
SEC EDGARMolina Healthcare 10-K for fiscal 2025
10
SEC EDGARMolina Healthcare 10-K for fiscal 2019
11
SEC EDGARMolina Healthcare 10-K for fiscal 2020
12
SEC EDGARMolina Healthcare 10-K for fiscal 2021
13
SEC EDGARMolina Healthcare 10-K for fiscal 2022
14
SEC EDGARMolina Healthcare 10-K for fiscal 2019
15
SEC EDGARMolina Healthcare 10-Q for fiscal 2026
16
SEC EDGARMolina Healthcare 10-Q for fiscal 2026
17
SEC EDGARJoseph M. Zubretsky, Chief executive officer
18
SEC EDGARGeorge Kirk Olsen, Chief executive officer
19
SEC EDGARJoann Zarza-Garrido, Chief executive officer
20
SEC EDGARRoman Kulich, Chief executive officer
21
SEC EDGARMark Lowell Keim, Chief financial officer
22
SEC EDGARJoseph W. Cpa White, Chief financial officer
23
SEC EDGARThomas L. Tran, Chief financial officer
24
SEC EDGARJohn C. Molina, Chief financial officer
25
SEC EDGARJames Woys, Chief operating officer
26
SEC EDGARTerry Bayer, Chief operating officer
27
SEC EDGARDebra Bacon, EVP, Medicaid
28
SEC EDGARMarc Russo, Executive Vice President
29
SEC EDGARMaurice Hebert, Chief Accounting Officer
30
SEC EDGARMark Lowell Keim, Executive Vice President
31
SEC EDGARPamela Sedmak, Executive Vice President
32
SEC EDGARJames Woys, Executive Vice President
33
SEC EDGARLisa A. Rubino, Senior Vice President
34
SEC EDGARMichael M. Siegel, Chief Medical Officer
35
SEC EDGARGeorge Kirk Olsen, VP, Molina Advantage
36
SEC EDGARJoann Zarza-Garrido, VP, Compliance
37
SEC EDGARJames W. Howatt, Chief Medical Officer
38
SEC EDGARAmir Desai, Chief Information Officer
39
SEC EDGARZarina Sparling, Regional Vice President
40
SEC EDGARHarvey A. Fein, VP, Internal Auditing
41
SEC EDGARJoseph W. Cpa White, VP, Accounting
42
SEC EDGARLillis Ann Koontz, VP, Health Plan Operations
43
SEC EDGARSheila Shapiro, Exec. VP, Shared Services
44
SEC EDGARRick Click, Chief Information Officer
45
SEC EDGARWilliam Bracciodieta, Chief Medical Officer
46
SEC EDGARJohn C. Molina, Exec. V.P., Financial Affairs
47
SEC EDGARFrancis S. Soistman Jr., Board member
48
SEC EDGARLeo P. Grohowski, Board member
49
SEC EDGARStephen H. Lockhart, Board member
50
SEC EDGARBarbara L. Brasier, Board member
51
SEC EDGARRichard C. Zoretic, Board member
52
SEC EDGARRichard M. Schapiro, Board member
53
SEC EDGARDale B. Wolf, Board member
54
SEC EDGARDaniel Cooperman, Board member
55
SEC EDGARGarrey Carruthers, Board member
56
SEC EDGARSteven J. Orlando, Board member
57
SEC EDGARCharles Z. Fedak, Board member
58
SEC EDGARFrank E. Murray Md., Board member
59
SEC EDGARJohn P. Szabo Jr., Board member
60
SEC EDGARRonna Romney, Board member
61
SEC EDGARSally K. Richardson, Board member
62
SEC EDGARWayne B. Lowell, Board member
63
SEC EDGARJeff D. Barlow, General counsel
64
SEC EDGARMark L. Andrews Esq., General counsel
65
SEC EDGARLingotto Investment Management LLP SCHEDULE 13G on Molina Healthcare
66
SEC EDGARAQR CAPITAL MANAGEMENT LLC SCHEDULE 13G/A on Molina Healthcare
67
SEC EDGARCapital World Investors SCHEDULE 13G/A on Molina Healthcare
68
SEC EDGARFMR LLC SCHEDULE 13G/A on Molina Healthcare
69
SEC EDGARVANGUARD CAPITAL MANAGEMENT LLC SCHEDULE 13G on Molina Healthcare
70
SEC EDGARVANGUARD PORTFOLIO MANAGEMENT LLC SCHEDULE 13G on Molina Healthcare
71
SEC EDGARBlackRock SCHEDULE 13G/A on Molina Healthcare
72
SEC EDGARVANGUARD GROUP INC SCHEDULE 13G/A on Molina Healthcare
73
SEC EDGARPRICE T ROWE ASSOCIATES INC /MD/ SCHEDULE 13G/A on Molina Healthcare
74
SEC EDGARCapital Research Global Investors SCHEDULE 13G/A on Molina Healthcare
75
SEC EDGARWellington Management Company SC 13G/A on Molina Healthcare
76
SEC EDGARRENAISSANCE TECHNOLOGIES LLC SC 13G/A on Molina Healthcare

Overview

Financials

Key numbers, fiscal 2025

Where the money goes

Where each dollar of revenue went, fiscal 2025

Financial statements

The story

Leadership

Chief executive

President

Chief financial officer

Chief operating officer

Products and brands

Entering the Medicare market

Entering MMIS market

Entering health insurance marketplace

Former names

Controversies and legal

Criticism and controversies

Timeline

Filings

Insider trades

Major holders

Held by these funds

Members of Congress who traded it

Links

Sources